Nirmatrelvir-ritonavir is prescribed for:
- Mild-to-moderate COVID-19
- Patients at high risk for severe disease
- Must start within 5 days of symptoms
- Immunology infectious disease
Reduces hospitalization and death risk by nearly 90%.
Generic Name: Nirmatrelvir/Ritonavir
Brand Names: Paxlovid
Paxlovid is an oral antiviral for mild-to-moderate COVID-19 in patients at high risk for severe disease.
Nirmatrelvir-ritonavir is prescribed for:
Reduces hospitalization and death risk by nearly 90%.
Common side effects:
Serious side effects:
Paxlovid combines nirmatrelvir (protease inhibitor) with ritonavir (booster) for COVID-19 treatment.
Ritonavir causes significant drug interactions - must review all medications before prescribing.
Some patients experience symptom recurrence after completing treatment (COVID rebound).
Learn more at MedlinePlus.
Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.
Loading questions...
Have questions about Paxlovid? Get expert answers from Dr. Zimmer.
Privacy: Your questions are posted anonymously for your health privacy. Your name and email are only used for admin purposes.
Questions are reviewed before posting. You'll see your question and Dr. Zimmer's answer below once approved.